G. G. Fleming, Découverte de la pénicilline, 2017.

A. A. , Resistance to antibiotics: are we in the post-antibiotic era, Arch Med Res, vol.36, issue.6, pp.697-705, 2005.

Z. M. , Antimicrobial peptides of multicellular organisms, Nature, vol.415, pp.389-95, 2002.

K. , N. P. , K. A. , C. O. , B. F. et al., In vitro activity of synthetic antimicrobial peptides against Candida, Pol J Microbiol, vol.55, pp.303-310

, Des acides aminés synthétiques pour de nouveaux peptides

. Hoffmann-s and . Outterson-k, What will it take to address the global threat of antibiotic resistance?, J Law Med Ethics Boston Univ Sch, 2015.

S. Rd, Antimicrobial resistance: a global response, Bull World Health Organ, vol.80, issue.2, pp.126-159, 2002.

W. Ellington-m, The emergence of antibiotic resistance by mutation, Clin Microbiol Infect, vol.13, issue.1, pp.5-18, 2007.

L. and D. A. Zaidi-a, Antibiotic resistance-the need for global solutions, Lancet Infect Dis, vol.13, issue.12, pp.1057-1098, 2013.

O. , Tackling Drug-Resistant Infections Globally: final report and recommendations. The review on microbial resistance, 2016.

W. Health-organization, Antimicrobial resistance : Global Report on Surveillance. WHO Library Cataloguing-in-Publication Data, 2014.

M. Dixon-dm and K. J. Antimicrobial-resistance, , vol.316, pp.1193-204, 2016.

E. Commission, Special Eurobarometer Antimicrobial resistance, 2016.

T. , S. T. , D. I. Bidino-r, M. , R. M. et al., Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy, Antimicrob Agents Chemother, vol.54, issue.10, pp.4085-91, 2010.

W. Health-organization, WHO publishes list of bacteria for which new antibiotics are urgently needed, 2017.

T. , H. M. , Y. E. , S. R. Bellasio, and J. Vardavas-r, Estimating the economic costs of antimicrobial resistance: Model and Results. RAND Corporation, 2014.

B. Bonten-m, G. C. Van-tiel-f, V. Der-geest-s, and . De,

L. , Indications for antibiotic use in ICU patients: a one-year prospective surveillance, Antimicrob Agents Chemother, vol.39, pp.527-562, 1997.

K. and F. V. , Antibiotic resistance in the intensive care unit, Ann Intern Med, vol.134, pp.298-314, 2001.

L. Brechot-n, T. J. , and C. , Antibiotic stewardship in the intensive care unit, Crit Care, vol.18, issue.5, p.480, 2014.

B. J. and G. D. Spellberg-b, Seven ways to preserve the miracle of antibiotics, Clininical Infect Dis, vol.56, issue.10, pp.1445-50, 2013.

L. Ventola-l, The Antibiotic Resistance Crisis. Part 1: Causes and Threats, Pharm Ther, vol.40, issue.4, pp.277-83, 2015.

, Best use of medicines legislation to bring new antibiotics to patients and combat the resistance problem

, Antimicrobial resistance in human medicine

, European medecines agency, 2016.

H. Ma, FDA"s Take on the Executive Order and National Strategy to Combat Antibiotic-Resistant Bacteria, 2014.

C. Langer and J. Slawomirski-l, Antimicrobial resistance in countries G7 Countries and beyond: Economic Issues, Policies and Options for Action, 2015.

, Un nouvel espoir de traitement des pneumonies graves

, Définition: Peptidomimétique. Le dictionnaire de l"Académie nationale de Pharmacie, 2015.

R. , Antimicrobial peptide mimics for improved therapeutic properties, Biochim Biophys Acta, issue.8, pp.1582-92, 1788.

A. E. , Cationic antimicrobial peptides: from innate immunity study to drug development. Update. Médecine Mal Infect, vol.37, pp.194-203, 2007.

D. , B. N. Weinberg-a, and O. Isich-k, The roles of antimicrobial peptides in innate host defense, Curr Pharm Des, vol.15, issue.21, pp.2377-92, 2009.

L. , X. Q. Zhang-q, Y. Huang, and S. Z. , Overview on the recent study of antimicrobial peptides: Origins, functions, relative mechanisms and application, Peptides, vol.37, issue.2, pp.207-222, 2012.

D. , B. N. Weinberg-a, and O. Isich-k, The Roles of Antimicrobial Peptides in Innate Host Defense, Curr Pharm Des, vol.15, issue.21, pp.2377-92, 2009.

W. G. , L. X. , and W. Z. , APD2: the updated antimicrobial peptide database and its application in peptide design, Nucleic Acids Res, vol.37, issue.1, pp.933-940, 2009.

Z. Wu, H. , L. H. , and L. G. Huang-q, LAMP: A Database Linking Antimicrobial Peptides, PLoS ONE, vol.8, issue.6, 2013.

B. Aa, Antimicrobial Peptides. Pharmaceuticals, vol.6, issue.12, pp.1543-75

M. Wh, Fleming"s "Lysozyme, Calif West Med, vol.56, issue.1, p.5, 1942.

M. Mm, C. Hawk-a, A. Jh, and . Rc, Treatment of War Wounds: A Historical Review, Clin Orthop Relat Res, vol.467, issue.8, pp.2168-91, 2009.

G. , M. , A. Jm, and R. , Plant defense peptides, Biopolymers, vol.47, pp.479-91, 1998.

G. and L. Ri, Defensins. Pharmacol Ther, vol.6, issue.4, pp.584-593, 1994.

F. Xm, S. Q. , C. Qx, S. Book-m, . Hg et al., Differential expression of alpha-and beta-defensins in human peripheral blood, Eur J Clin Invest, vol.33, pp.82-89, 2003.

H. , K. F. , and J. C. Ezekowitz-r, Phylogenetic perspectives in innate immunity, Science, vol.284, issue.55418, pp.1313-1321, 1999.

K. S. , Dictionnaire des Sciences pharmaceutiques et biologiques de l"Académie nationale de Pharmacie

. Brogden-k, Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?, Nat Rev Microbiol, vol.3, issue.3, pp.238-50, 2005.

J. and H. P. Hancock-rew, Peptide Antimicrobial Agents, Clin Microbiol Rev, vol.19, issue.3, pp.491-511, 2006.

L. Gallo-rl, Antimicrobial peptides : Discovery, design and novel therapeutic strategies, Trends Immunol, vol.30, issue.3, pp.131-172, 2009.

P. Jp and . Hancock-re, The relationship between peptide structure and antibacterial activity, Peptides, vol.24, issue.11, pp.1681-91

N. J. , The medicinal chemistry of peptides, Curr Med Chem, vol.16, issue.33, pp.4399-418, 2009.

N. Lt, H. Ef, and V. Hj, The expanding scope of antimicrobial peptide structures and their modes of action, Trends Biotechnol, vol.29, issue.9, pp.464-72, 2011.

Y. Mr and Y. Ny, Mechanisms of antimicrobial peptide action and resistance, Pharmacol Rev, vol.55, issue.1, pp.27-55

S. Y. , Mode of action of membrane active antimicrobial peptides, Biopolymers, vol.66, issue.4, pp.236-284, 2002.

S. Y. , Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides, Biochim Biophys Acta, vol.1462, issue.1-2, pp.55-70, 1999.

M. K. , Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes, Biochim Biophys Acta, vol.1462, issue.1-2, pp.1-10, 1999.

F. Hoffmann-t, Peptide therapeutics, current status and future directions, vol.20, pp.122-130, 2015.

M. , Peptides and Peptidomimetics for antimicrobial drug design, Pharmaceuticals, vol.8, issue.3, pp.366-415, 2015.

G. and L. E. Mouah-h, Resistance to antimicrobial peptides in Gram-negative bacteria, FEMS Microb Lett, vol.330, issue.2, pp.81-90, 2012.

N. , C. Ek, and M. Sm, Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria, Antibiotics, vol.3, issue.4, pp.461-92, 2014.

V. Qu, H. , and H. Vj, Peptidomimetics, a synthetic tool of drug discovery, Curr Opin Chem Biol, vol.12, issue.3, pp.192-296, 2008.

R. P. , Peptides and peptidomimetics in Medicinal Chemistry, 2012.

G. , Peptidomimetics in Organic and Medicinal Chemistry, vol.308, 2014.

M. Soltani-s, A. Am, and . Sardari-s, Peptidomimetics and their Applications in Antifungal Drug Design, Anti-Infect Agents Med Chem, vol.8, issue.4, pp.327-371

B. Nk and . Brogden-ka, Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?, Int J Antimicrob Agents, vol.38, issue.3, p.21, 2011.

G. Ak and H. Vj, Investigational peptide and peptidomimetic ? and ? opioid receptor agonists in the relief of pain, Expert Opin Investig Drugs, vol.23, issue.2, 2014.

E. Ma and R. Dh, Peptidomimetics for drug design, vol.1, pp.663-685, 2003.

D. , Polymer-Based Synthetic Mimics of Antimicrobial Peptides (SMAMPs)-A New Class of Nature-Inspired Antimicrobial Agents with Low Bacterial Resistance Formation Potential, Macromol Chem Phys, vol.10, 2014.

P. A. , Pari gagné pour les peptides, vol.3157, 2009.

U. , K. T. , M. Fg, O. Ca, and H. D. Hillsa-d, The emergence of peptides in the pharmaceutical business: From exploration to exploitation, EuPA Open Proteomics, vol.4, pp.58-69, 2014.

F. , J. S. , L. A. , and W. Sh, Folding amphipathic helices into membranes: amphiphilicity trumps hydrophobicity, J Mol Med Berl, vol.370, issue.3, pp.549-470, 2007.

E. , EMA Annual Report, 2015.

E. , EMA Annual report, 2016.

H. R. , Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery, Nature, vol.354, issue.6348, pp.84-90, 1991.

B. Bender-s, Molecular recognition of protein-ligand complexes: applications to drug design, Chem Rev, vol.97, issue.5, pp.1359-472, 1997.

P. G. , Recent advances in the design and synthesis of peptidomimetics, 2001.

A. Blomberg-l, F. M. , L. L. Nilsson-b, and . Verlander-m, Large-scale synthesis of peptides, Biopolymers, vol.55, issue.3, pp.227-50, 2000.

G. As and . Satyanarayanajois-s, Peptides ad peptidomimetics as immunodulators, Immunotherapy, vol.6, issue.6, pp.755-74, 2014.

C. Beyermann-m and . Biener-m, Solid-phase peptide synthesis: from standard procedures to the synthesis of difficult of difficult sequences, Nat Protoc, vol.13, issue.12, pp.3247-56, 2007.

N. A. , Synthesis of Novel Amino Acids and Peptidmimetics as Tools for Drug Discovery, 2013.

M. , A. F. , and D. Pe, Methods, setup and safe handling for anhydrous hydrogen fluoride cleavage in Boc solid-phase peptide synthesis, Nat Protoc, vol.10, pp.1067-83, 2015.

L. , Z. P. De-clercq-e, and L. H. Liu-x, Current drug research on PEGylation with small molecular agents, Prog Polym Sci, vol.38, issue.3-4, pp.421-465, 2013.

H. Jm and C. Rb, Effect of pegylation on pharmaceuticals, Nat Rev Drug Discov, vol.2, pp.214-235, 2003.

G. Pirri and G. Nicoletto-s, Antimicrobial peptides: an overview of a promising class of therapeutics, Cent Eur J Biol, vol.2, issue.1, pp.1-33, 2007.

L. and B. Gs, Recent approaches in design of peptidomimetics for antimicrobal drug discovery research, Rev Med Chem, vol.13, issue.7, pp.1073-88

G. , Peptidomimetics-a versatile route to biologically active compounds, Eur J Org Chem, vol.30, issue.30, pp.5099-111, 2009.

B. , K. A. , G. A. Shalit-i, and . Fridkin-m, Chirality, antimicrobial activity and proteolytic resistance, FEBS Lett, vol.274, issue.1-2, pp.151-156, 1990.

M. Ap, G. Bf, and . Laverty-g, Evolution of Antimicrobial Peptides to Self-Assembled Peptides for Biomaterial Applications. Pathogens, vol.3, pp.791-821, 2014.

H. , S. S. , B. M. Torres-v, and K. , A comparison of linear and cyclic peptoid oligomers as potent antimicrobial agents, ChemMedChem, vol.7, issue.1, pp.114-136, 2012.

G. Benincasa-m, B. G. , B. B. , D. R. , and P. E. , Substitution of the arginine/leucine residues in apidaecin ib with peptoid residues: Effect on antimicrobial activity, cellular uptake, and proteolytic degradation, J Med Chem, vol.52, issue.16, pp.5197-206, 2009.

Y. and D. L. Zhang-x, Efficacy of oral etoposide in pretreated metastatic breast cancer: A multicenter phase 2 study. Medicine (Baltimore), vol.94, p.1, 2015.

M. , Oligoarginine-PEG-lipid particles for gene delivery, Expert Opin Drug Deliv, vol.10, issue.10, pp.1065-77, 2009.

K. , Nanotechnology advances in controlled drug delivery systems, Phys Status Sol C-Curr Top Solid State Phys, vol.5, issue.12, pp.3828-3861, 2008.

A. , H. Cd, and K. Ar, Peptidomimetics via modifications of amino acids and peptide bonds, Chem Soc Rev, vol.43, issue.10, pp.3575-94, 2014.

P. Gm, Peptidomimetics designed for oral absorption, Advanced in Amino Acid Mimetics and Peptidomimetics, pp.89-123, 1999.

A. , M. M. , K. V. , and M. , Therapeutic application of peptides and proteins: parenteral forever?, Trends Biotechnol, vol.27, issue.11, pp.628-663, 2009.

P. Rw and M. Mc, Peptide formulation: challenges and strategies Payne, Innov Pharm Technol, p.4, 2009.

V. Fm, Peptide and protein PEGylation: a review of problems and solutions, Biomaterials, vol.22, pp.405-422, 2001.

B. L. , Peptide PEGylation: The Next Generation. Pharm Technol, vol.11, 2011.

. Découvrir-de-nouveaux-médicaments, De la molécule aux tests finaux, tous les détails de sa conception

L. R. , The future of peptide development in the pharmaceutical industry, PharManufacturing Int Pept Rev, pp.10-15, 2013.

G. S. , Peptide therapeutics market: forecast and analysis 2015-2025, Oligos Pept-Chim Oggi-Chem Today, vol.34, issue.2, 2016.

, amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use, COMMISSION DIRECTIVE 2003/63/EC of 25, 2003.

, Assessment report for Bydureon, 2011.

F. J. , Antimicrobial peptides stage a comeback, Nat Biotechnol, vol.31, issue.5, pp.379-82, 2013.

M. , Peptidomimetics as a new generation of antimicrobial agents: current progress, Infect Drug Resist, vol.2014, issue.7, pp.229-266

W. G. , Human Antimicrobial Peptides and Proteins, Pharmaceuticals, vol.7, issue.5, pp.545-94, 42014.

K. , R. M. Sharma-pc, and Y. Ms, Therapeutic importance of peptidomimetics in medicinal chemistry, J Chem Pharm Res, vol.3, issue.6, pp.173-86, 2011.

T. , S. R. Klein-m, and . Degrado-w, De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications, Acc Chem Res, vol.43, issue.1, pp.30-39, 2010.

B. , S. Mr, and H. Jm, Nisin, alone and combined with peptidoglycan-modulating antibiotics: Activity against methicillin-resistant

, Staphylococcus aureus and vancomycin-resistant enterococci, J Antimicrob Chemother, vol.50, pp.731-734, 2002.

Y. Biragyn-a, K. Lw, and O. , Mammalian defensins in immunity: more than just microbicidal, Trends Immunol, vol.23, pp.291-297, 2002.

M. As, A la decouverte des peptides antimicrobiens

, Universite Henri Poincare-Nancy 1, 2010.

Z. M. , Magainins, a class of antimicrobial peptides from Xenopus skin: Isolation, characterization of two active forms, and partial cDNA sequence of a precursor, Proc Natl Acad Sci, vol.84, pp.5449-5453, 1987.

A. Rodriguez-a, R. L. Francino-o, and A. , Safety and efficacy of antimicrobial peptides against naturally acquired leishmaniasis, Antimicrob Agents Chemother, vol.48, pp.641-643, 2004.

P. , J. Sh, L. Dg, and H. Ks, Antinematodal effect of antimicrobial peptide, p.23

, J Pept Sci, vol.10, pp.304-311

G. D. Veiga-s and C. , From antimicrobial to anticancer peptides. A review. Front Microbiol, vol.4, pp.1-16, 2013.

B. Rj, L. Mw, V. P. Perez, J. M. , and K. Ar, The Use of Therapeutic Peptides to Target and to Kill Cancer Cells, Curr Med Chem, vol.19, issue.22, pp.3794-3804, 2012.

T. M. , Le virus de l"immunodéficience humaine, 2005.

G. , Chemical Stability of New Acyclovir Analogues with Peptidomimetics, Sci Pharm, vol.79, issue.2, pp.259-64, 2010.

K. Matsumoto, H. , Y. S. , and K. , Design of small peptidomimetic HIV-1 protease inhibitors and prodrug forms, Lett Pept Sci, vol.6, issue.5, pp.275-81, 1999.

P. Market, Advancements in the field of Synthetic Peptides and emergence of prominent biopharmaceutical companies are fuelling the growth: Global Industry Analysis and Opportunity Assessment, Future Mark Insights, vol.172, pp.2015-2025, 2016.

C. Dj, F. Dp, L. S. , and P. D. , The future of peptide-based drugs, Chem Biol Drug Des, vol.81, issue.1, pp.136-183, 2013.

Z. M. , Multifunctional antimicrobial peptides: therapeutic targets in several human diseases, J Mol Med Berl, vol.85, issue.4, pp.317-346, 2007.

G. and R. Ac, Beyond natural antimicrobial peptides : multimeric peptides and other peptidomimetic approaches, Cell Mol Life Sci, vol.68, issue.13, pp.2255-66, 2011.

Q. , R. Sjs, U. Tj, M. , and G. Er, Peptidomimetic therapeutics: scientific approaches and opportunities, Drug Discov Today, vol.0, issue.0, pp.1-9, 2016.

H. C. , Le business model cassé des antibiotiques. Le monde, 2004.